...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Equity financing

Someone posted the subscription agreement a couple weeks ago. As far as I have heard the financing is still on, unchanged.

tada

Share
New Message
Please login to post a reply